Peptide aptamers: New tools to study protein interactions

Journal of Steroid Biochemistry and Molecular Biology

Volumn 78, Issue 2, 2001, Pages 105-111

  Hoppe Seyler, F ^a   Crnkovic Mertens, I ^a   Denk, C ^a   Fitscher, B A ^a   Klevenz, B ^a   Tomai, E ^a   Butz, K ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Drug design; Hepatitis B virus; Human papillomavirus; Peptides; Protein therapy; Proteomics; Review; Yeast two hybrid

Indexed keywords

APTAMER; GAMMA INTERFERON; LAMIVUDINE; PEPTIDE;

AMINO ACID SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; NONHUMAN; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; WART VIRUS; YEAST;

ANTIVIRAL AGENTS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; DNA-BINDING PROTEINS; DRUG DESIGN; E2F TRANSCRIPTION FACTORS; ONCOGENE PROTEINS, VIRAL; PEPTIDES; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; VIRAL CORE PROTEINS;

HEPATITIS B VIRUS; HUMAN PAPILLOMAVIRUS;

EID: 0034836677     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00085-1     Document Type: Short Survey

References (39)

1. A novel genetic system to detect protein-protein interactions
2. Tag games in yeast: The two-hybrid system and beyond
3. The impact of two-hybrid and related methods on biotechnology
4. Genetic characterization of a mammalian protein-protein interaction domain using a yeast reverse two-hybrid system
5. Protein-protein interactions: Methods for detection and analysis
6. Selection of antibodies for intracellular function using a two-hybrid in vivo system
7. The selection of intracellular antibodies
8. The two-hybrid system: An assay for protein-protein interactions
9. Protein-peptide interactions analyzed with the yeast two-hybrid system
10. Constrained peptides as binding entities
11. Structural and mechanistic determinants of affinity and specificity of ligands discovered or engineered by phage display
12. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2
13. Genetic selection of peptide inhibitors of biological pathways
14. An artificial cell-cycle inhibitor isolated from a combinatorial library
15. Tendamistat as a scaffold for conformationally constrained phage peptide libraries
16. Selection of peptides that functionally replace a zinc finger in the Sp1 transcription factor by using a yeast combinatorial library
17. Green fluorescent protein as a scaffold for intracellular presentation of peptides
18. Transdominant genetic analysis of a growth control pathway
19. Mutagenesis by peptide aptamers identifies genetic network members and pathway connections
20. Dominant effector genetics in mammalian cells
21. Targeting cyclin-dependent kinases in Drosophila with peptide aptamers
22. The E2F transcription factors: Key regulators of cell proliferation
23. Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity
24. Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein
25. Papillomavirus infections - A major cause of human cancers
26. Human tumor viruses
27. Hepadnaviridae and their replication
28. Clinical aspects of hepatitis B virus infection
29. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
30. Minimized proteins
31. Isolation of peptide aptamers that inhibit intracellular processes
32. Recent developments in structural-based drug design
33. Protease inhibitors: Current status and future prospects
34. Drug delivery and targeting
35. Improving protein therapeutics with sustained-release formulations
36. Therapeutic peptides revisited
37. In vivo protein transduction: Intracellular delivery of biologically active proteins, compounds and DNA
38. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation
39. Peptides aptamers targeting the hepatitis B virus core protein: A new class of molecules with antiviral activity